“As the leader in cardiovascular diagnostic insights, Quest Diagnostics brings a remarkable network of just-in-time clinical and consumer diagnostics, access to rich longitudinal data, and the logistical framework to quickly translate science into actionable insights for the people who seek ways to preempt heart disease,” said Nancy Brown, CEO, AHA.